Agios Pharmaceuticals (AGIO) Non-cash Items (2016 - 2017)

Agios Pharmaceuticals (AGIO) has disclosed Non-cash Items for 6 consecutive years, with $104.5 million as the latest value for Q1 2017.

  • For Q1 2017, Non-cash Items rose 44.09% year-over-year to $104.5 million; the TTM value through Mar 2017 reached $104.5 million, up 44.09%, while the annual FY2016 figure was $63.6 million, 2903.87% up from the prior year.
  • Non-cash Items hit $104.5 million in Q1 2017 for Agios Pharmaceuticals, up from $63.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $360.9 million in Q4 2014 and bottomed at $1.6 million in Q3 2014.
  • Average Non-cash Items over 5 years is $68.7 million, with a median of $33.2 million recorded in 2013.
  • Year-over-year, Non-cash Items surged 4472.1% in 2014 and then tumbled 98.58% in 2015.
  • Agios Pharmaceuticals' Non-cash Items stood at $76.2 million in 2013, then soared by 373.74% to $360.9 million in 2014, then tumbled by 57.45% to $153.6 million in 2015, then tumbled by 58.61% to $63.6 million in 2016, then surged by 64.41% to $104.5 million in 2017.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $104.5 million, $63.6 million, and $2.6 million for Q1 2017, Q4 2016, and Q3 2016 respectively.